药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

已收盘 03-06 16:08:19

112.000

+3.500

+3.23%

最高112.400	最低107.700	成交量400.07万
今开108.000	昨收108.500	日振幅4.33%
总市值3,342亿	流通市值571.73亿	总股本29.84亿
成交额4.46亿	换手率0.78%	流通股本5.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":112,"timestamp":1772784499006,"preClose":108.5,"halted":0,"volume":4000738,"delay":0,"changeRate":0.03225806451612903,"floatShares":510476909,"shares":2984000000,"eps":3.0912021097645894,"marketStatus":"已收盘","change":3.5,"latestTime":"03-06 16:08:19","open":108,"high":112.4,"low":107.7,"amount":445666417,"amplitude":0.043318,"askPrice":112.1,"askSize":71800,"bidPrice":112,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":5.997215373220039,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":108.5,"dividendRate":0.013488,"openAndCloseTimeList":[[1772760600000,1772769600000],[1772773200000,1772784000000]],"volumeRatio":0.927241,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":93.3,"timestamp":1772780400000,"preClose":92.45,"halted":0,"volume":26855600,"delay":0,"premium":"+5.87"},"impliedVol":0.1628,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/02359/wiki","defaultTab":"wiki","newsList":[{"id":"2617506348","title":"药明康德盘中异动 股价大涨3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617506348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617506348?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:12","pubTimestamp":1772763124,"startTime":"0","endTime":"0","summary":"2026年03月06日早盘10时12分，药明康德股票出现异动，股价大幅拉升3.13%。截至发稿，该股报111.900港元/股，成交量71.3316万股，换手率0.14%，振幅3.87%。资金方面，该股资金流入4050.31万港元，流出3235.43万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体涨幅为2.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306101204a6a8efb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306101204a6a8efb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2045819591.USD","BK1576","LU1046422090.SGD","02359","LU2125910500.SGD","LU0708995583.HKD","BK1141","LU0320764599.SGD","BK1583","LU2242644610.SGD"],"gpt_icon":0},{"id":"2617208528","title":"每日卖空追踪 | 药明康德 03月05日卖空量成交43.99万股，卖空比例为11.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617208528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617208528?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699431,"startTime":"0","endTime":"0","summary":"药明康德北京时间03月05日，跌0.37%，卖空量成交43.99万股，较上一交易日减少69.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163406a6a5d928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163406a6a5d928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","02359","BK1583","LU0320764599.SGD","LU1046422090.SGD","LU2242644610.SGD","BK1141","LU2125910500.SGD","LU0052750758.USD","LU2045819591.USD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2617528267","title":"无锡药明康德新药开发股份有限公司发布2026年2月证券变动月报","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528267","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617528267?lang=zh_cn&edition=full","pubTime":"2026-03-05 00:50","pubTimestamp":1772643000,"startTime":"0","endTime":"0","summary":"中访网数据无锡药明康德新药开发股份有限公司于2026年3月4日向香港交易及结算所有限公司提交了截至2026年2月28日的证券变动月报表。报告显示，公司股本结构在报告期内保持稳定。公司已发行股本总额为人民币2,983,757,155元，由A股和H股构成。报告期内，公司未发生因股份期权、权证、可换股票据或其他协议安排导致的已发行股份或库存股份变动。公司亦确认，本月无香港预托证券的相关资料需披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305005121a44c0d65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305005121a44c0d65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","LU0052750758.USD","LU0708995583.HKD","BK1141","LU2045819591.USD","LU0320764599.SGD","BK1583","LU2242644610.SGD","02359","LU1046422090.SGD","BK1576"],"gpt_icon":0},{"id":"1131679409","title":"摩根大通增持药明康德H股 持股比例从7.14%升至8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131679409","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131679409?lang=zh_cn&edition=full","pubTime":"2026-03-04 18:13","pubTimestamp":1772619195,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露的数据，摩根大通于2月26日对药明康德H股（股份代号：02359）的持股比例出现显著变动。该机构持有的多头头寸从原先的7.14%提升至8.32%，显示出其对药明康德发展前景的持续看好。\n此次增持动作进一步巩固了摩根大通作为药明康德重要股东的地位。持股比例的提升往往被市场解读为机构投资者对企业基本面和未来成长潜力的积极预期。药明康德作为全球领先的医药研发外包服务平台，其业务布局和技术实力一直受到资本市场的广泛关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245094.SGD","02359","LU2242644610.SGD","BK1141","LU1997245177.USD","LU2045819591.USD","LU0052750758.USD","LU2495084118.USD","LU0708995583.HKD","BK1583","LU1997244956.HKD","LU2125910500.SGD","LU0320764599.SGD","LU1046422090.SGD","BK1576","LU0456842615.SGD","LU2488822045.USD","LU1969619763.USD","LU2328871848.SGD","LU1808992512.USD","LU1934453819.USD","603259","BK0216","LU1979443071.USD"],"gpt_icon":0},{"id":"1183074387","title":"药明康德（02359）2月股份变动月报：股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1183074387","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183074387?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:54","pubTimestamp":1772614492,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司于2026年3月4日发布截至2026年2月28日的股份变动月报。公告显示，公司本月无新增发行、购回或注销股份活动，整体股本维持不变。报告期内，药明康德H股已发行股本数量为510,476,909股，A股已发行股本数量为2,473,280,246股，两类股份合计已发行股本总数为2,983,757,155股。公司在公告中确认，截至本月底继续符合香港联交所主板上市规则有关公众持股量的规定。总体来看，药明康德在2月期间股本结构保持稳定，未发生股份变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"gpt_icon":0},{"id":"2616587844","title":"药明康德盘中异动 股价大跌3.02%报109.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587844","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587844?lang=zh_cn&edition=full","pubTime":"2026-03-04 09:31","pubTimestamp":1772587898,"startTime":"0","endTime":"0","summary":"2026年03月04日早盘09时31分，药明康德股票出现异动，股价急速跳水3.02%。截至发稿，该股报109.000港元/股，成交量15.5947万股，换手率0.03%，振幅2.67%。资金方面，该股资金流入508.356万港元，流出402.801万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体跌幅为0.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040931389542de1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040931389542de1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","02359","LU0320764599.SGD","BK1576","LU0052750758.USD","LU0708995583.HKD","LU2045819591.USD","BK1583","LU2125910500.SGD","BK1141","LU1046422090.SGD"],"gpt_icon":0},{"id":"2616587848","title":"每日卖空追踪 | 药明康德 03月03日卖空量成交44.52万股，卖空比例为12.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587848?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526631,"startTime":"0","endTime":"0","summary":"药明康德北京时间03月03日，跌2.43%，卖空量成交44.52万股，较上一交易日减少47.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163414a69cabf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163414a69cabf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","BK1583","LU2125910500.SGD","LU0052750758.USD","BK1576","02359","BK1141","LU0320764599.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2616311293","title":"药明康德：公司一直秉承“跟随科学、跟随客户、跟随分子”的战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2616311293","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616311293?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:09","pubTimestamp":1772453378,"startTime":"0","endTime":"0","summary":"证券日报网讯3月2日，药明康德在互动平台回答投资者提问时表示，公司多年来的持续增长来源于公司独特的一体化CRDMO业务模式，为全球客户提供兼具“质量、速度、成本”的解决方案，以及全球团队持续高效的执行力。公司一直秉承“跟随科学、跟随客户、跟随分子”的战略，通过公司独特的CRDMO业务模式，迅速产生行业洞见，前瞻性布局新能力，及时服务客户新分子需求，驱动公司长期发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603023658761843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","LU1997245094.SGD","LU1969619763.USD","LU1934453819.USD","BK1583","LU1997244956.HKD","LU1997245177.USD","BK1141","BK0216","LU0052750758.USD","LU0456842615.SGD","BK1576","LU0320764599.SGD","LU1979443071.USD","603259","LU0708995583.HKD","LU1808992512.USD","LU2488822045.USD","LU1046422090.SGD","LU2328871848.SGD","LU2045819591.USD","LU2495084118.USD","LU2125910500.SGD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2616784879","title":"每周股票复盘：药明康德（603259）现大宗交易机构净买入254.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616784879","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616784879?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:33","pubTimestamp":1772299990,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，药明康德（603259）报收于98.01元，较上周的101.91元下跌3.83%。本周，药明康德2月24日盘中最高价报103.88元。2月27日盘中最低价报97.18元。药明康德当前最新总市值2924.38亿元，在医疗服务板块市值排名1/51，在两市A股市值排名44/5189。本周关注点来自交易信息汇总：药明康德2月27日发生1笔大宗交易，机构净买入254.83万元交易信息汇总2月27日药明康德现1笔大宗交易，机构净买入254.83万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","LU2495084118.USD","BK1583","LU2125910500.SGD","LU1979443071.USD","LU1997245177.USD","LU2488822045.USD","LU1808992512.USD","BK1576","LU1934453819.USD","LU0320764599.SGD","LU2045819591.USD","LU1969619763.USD","LU2242644610.SGD","02359","LU2328871848.SGD","LU0708995583.HKD","LU0456842615.SGD","BK0216","LU1046422090.SGD","LU0052750758.USD","LU1997244956.HKD","LU1997245094.SGD","BK1141"],"gpt_icon":0},{"id":"2616827182","title":"医药生物行业周报：GSK联手中国新锐 SIRNA赛道布局再下一城","url":"https://stock-news.laohu8.com/highlight/detail?id=2616827182","media":"开源证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616827182?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"GSK 携手前沿生物加速布局siRNA，中国企业研发实力正获国际认可GSK 重点合作布局小核酸，已具有多款重磅管线。据Insight 统计，自2009 年起，GSK 已进行多起小核酸相关BD 交易，其中较多集中于ASO 和siRNA 领域。siRNA 领域，GSK 延续早期ASO 所布局的乙肝类管线协同性，与Arrowhead、WAVE 等企业在肝脏相关疾病领域着力布局。本周医药生物上涨0.5%，跑输沪深300 指数0.58pct，在31 个子行业中排名第25 位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301204231a43e2281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1161","02359","BK1593","01530","BK1583","HK0000165453.HKD"],"gpt_icon":0},{"id":"2616826552","title":"医药行业周报：哮喘与COPD：长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点：哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提；行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势，同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978","BK1576","02359","BK1583","03347","BK1141","02269"],"gpt_icon":0},{"id":"2614240835","title":"2月27日药明康德现1笔大宗交易 机构净买入254.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614240835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614240835?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:24","pubTimestamp":1772184268,"startTime":"0","endTime":"0","summary":"证券之星消息，2月27日药明康德发生大宗交易，交易数据如下：大宗交易成交价格98.01元，成交2.6万股，成交金额254.83万元，买方营业部为机构专用，卖方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部。近三个月该股共发生62笔大宗交易，合计成交30.14万手，折价成交56笔，溢价成交1笔。截至2026年2月27日收盘，药明康德报收于98.01元，上涨0.0%，换手率0.95%，成交量23.51万手，成交额23.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700029042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","LU1969619763.USD","LU1808992512.USD","LU1997244956.HKD","BK1141","LU2045819591.USD","LU1046422090.SGD","BK1576","02359","LU0320764599.SGD","LU0708995583.HKD","LU1934453819.USD","603259","BK1583","LU2125910500.SGD","LU1997245177.USD","LU1997245094.SGD","LU0052750758.USD","LU2488822045.USD","LU1979443071.USD","LU2242644610.SGD","LU0456842615.SGD","LU2328871848.SGD","LU2495084118.USD"],"gpt_icon":0},{"id":"2614887215","title":"智通AH统计|2月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2614887215","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614887215?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180105,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止2月27日收盘，东北电气、浙江世宝、京城机电股份分列AH溢价率前三位，溢价率分别为575.00%、357.86%、291.22%；宁德时代、招商银行、药明康德分列AH溢价率末三位，溢价率分别为-16.67%、-4.75%、-1.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348825331.USD","LU1655091459.SGD","LU0149534421.HKD","BK1258","LU0878005551.USD","LU0293314216.USD","LU0348735423.USD","LU0315179316.USD","IE00BZ08YR35.GBP","159982","LU0254981946.USD","LU0828237510.HKD","LU0328353924.USD","LU0594300179.USD","SG9999002562.SGD","LU1675838814.USD","LU0588545730.USD","LU0856984785.SGD","BK1147","SG9999002828.SGD","LU0370786039.SGD","IE00BVYPNP33.GBP","IE00B5MMRT66.SGD","LU0791591158.USD","LU1282648689.USD","LU1981816686.USD","LU0072462343.USD","LU0878004406.USD","LU0084288322.USD","IE00BZ08YS42.EUR","LU0456827905.SGD","LU2543165471.USD","BK1505","BK1184","LU1051769294.HKD","LU1642822792.SGD","LU1366334651.USD","399300","LU0823426308.USD","LU0675040207.SGD","IE0008368742.USD","BK1592","LU0348788117.USD","LU1785774172.SGD","LU1655091616.SGD","LU0049853897.USD","LU0307460666.USD","03968","BK1144","LU0051755006.USD","LU2097828631.EUR","LU0605514214.HKD","HPAD.SI","LU0417516571.SGD","01057","LU1328277881.USD","LU2778985437.USD","LU0348784397.USD","IE00BZ08YT58.USD","002703","LU1211504680.USD","IE00B031J352.USD","LU0831093199.SGD","LU0164880469.USD","BK1522","LU0797268264.HKD","LU2097828714.EUR","LU0882747503.HKD","LU1769817179.HKD","LU1242518857.USD","LU1807302812.USD","LU0327786744.USD","LU0819121731.USD","LU0972618739.USD","600036","IE00BPRC5H50.USD","LU0106252389.USD","LU0593848301.USD","LU0235996351.USD","LU0501845795.SGD","LU1044874839.SGD","LU0531971595.HKD","SG9999006597.SGD","LU2097828805.USD","BK1141","LU0456854461.SGD","LU0607220059.USD","BK1538","HK0000320223.HKD","LU1770034418.SGD","SG9999014674.SGD","LU0117844026.USD","LU1820825898.SGD","LU0828237940.HKD","BK1198","LU0898667661.SGD","LU0049112450.USD","LU1960683339.HKD","BK1202","LU0043850808.USD","PNGAY","LU0196878994.USD","LU0231483743.USD","LU0244354667.USD","LU0880133367.SGD","LU1224709979.USD","LU0449515922.USD","LU0345780281.USD","LU0469268626.HKD","LU1719994722.HKD","LU0509642566.USD","LU0488056044.USD","LU1769817096.USD","LU0516422366.SGD","LU0648948544.HKD","LU1366334578.USD","LU1105468828.SGD","601318","LU0463099449.HKD","LU2348774022.SGD","BK1515","LU0588546209.SGD","HK0000352382.USD","BK1543","LU1303224171.USD","LU2125910500.SGD","LU0620787316.HKD","IE0008369823.USD","LU0516422440.USD","LU0979878070.USD","LU0594300419.USD","BK1161","00042","BK1509","LU0868486357.SGD","BK1544","LU0762540952.USD","BK1240","SG9999002463.SGD","LU0708995583.HKD","LU0211977185.USD","LU2226246903.HKD","IE0031814852.USD","LU1146622755.USD","LU1282649810.SGD","LU3063872942.SGD","LU0329678170.USD","IE00BMCWC346.EUR","LU1044876610.USD","LU0329678337.USD","LU0210527791.USD","BK1516","BK1550","LU0348805143.USD","LU0287142896.SGD","LU0737861699.HKD","LU0589944569.HKD","LU0634319403.HKD","LU0266512473.USD","SG9999000459.SGD","LU1235295612.USD","LU0651947912.USD","BK1610","LU0314109678.HKD","300750","LU1023057109.AUD","LU0819123356.HKD","LU1880383366.USD","LU0054450605.USD","LU1720050803.USD","LU0918141705.HKD","IE00B543WZ88.USD","LU2399975544.HKD","BK1205","HK0000320264.USD","BK1229","LU0821914370.USD","LU0572944931.SGD","03143","IE0032431581.USD","LU1880383440.USD","BK1523","LU0791590937.USD","LU0228367735.SGD","LU0862451837.USD","SG9999001903.USD","BK1574","LU0784639295.USD","LU1504937902.USD","03145","LU1048588211.SGD","BK1183","LU2097828557.USD","LU2097828474.EUR","IE00BGHQDM52.EUR","CIHKY","LU0456846285.SGD","LU2153592121.USD","LU1813983027.USD","LU0540923850.HKD","BK1594","BK1501","LU0384037296.USD","LU0320764599.SGD","LU1688375341.USD","LU0831103253.SGD","BK1174","LU0348827113.USD","LU0164872284.USD","LU1481107354.HKD","LU0082770016.USD","LU0229945570.USD","LU2153591404.USD","LU2476274720.SGD","LU0359201885.HKD","LU0611395673.USD","BK1231","LU1993786604.SGD","BK1193","LU0651946864.USD","LU0140636845.USD","00187","LU0417516738.SGD","LU0737861772.HKD","LU1242518931.SGD","LU0117841782.USD","BK1171","LU1046422090.SGD","LU0516423174.USD","03750","LU2152927971.USD","LU0048580855.USD","LU0502904849.HKD","LU0588545490.SGD","BK1148","HK0000352291.HKD","LU0823426480.USD","LU0197773160.USD","LU0871576103.HKD","02359","LU1515016050.SGD","LU0269904917.USD","LU0345780521.USD","LU2045819591.USD","LU1051768304.USD","BK1214","LU0455707207.USD","LU0165289439.USD","HK0000306685.HKD","LU0348814723.USD","BK1116","LU1152091168.USD","LU0011963245.USD","BK1562","LU0149721374.USD","LU1282649067.USD","IE00B031HY20.USD","LU0163747925.USD","LU0828238088.HKD","LU0588545904.SGD","IE00B29SXG58.USD","BK1564","LU1188198961.HKD","LU0441854154.USD","LU0359202008.SGD","LU0359201612.USD","LU1282651121.HKD","IE00BF5LJ272.USD","BK1191","BK1554","LU0348783233.USD","IE0034224299.USD","LU0061477393.USD","LU0630378429.USD","LU1831875114.USD","BK1105","82318","LU2242644610.SGD","BK1237","BK1546","BK1149","LU0516422952.EUR","LU0348816934.USD","LU0640798160.USD","BK1178","LU1152091754.HKD","LU0650527681.SGD","LU1282651048.USD","LU0039217434.USD","LU0164939612.USD","BK1200","BK1576","BK1507","LU0315178854.USD","LU0348783662.USD","LU0197773673.USD","BK1521","LU0266512127.USD","LU0886674414.USD","LU0890818403.SGD","LU0918141887.USD","LU1226287529.USD","LU0052750758.USD","LU0082770016.SGD","IE0003895053.USD","LU0561508036.HKD","LU0106959298.USD","LU0431992006.USD","LU1224444064.USD","LU0072913022.USD","PAImain","HK0000306701.USD","BK1506","LU1282649141.HKD","LU0228659784.USD","LU0862451753.SGD","LU2039709279.SGD","LU1048596156.SGD","LU0762542818.HKD","IE00BYV24P56.USD","LU0067412154.USD","LU1961090484.USD","BK1560","LU1794554557.SGD","LU0164865239.USD","LU0630378692.HKD","LU2348773727.SGD","SG9999004220.SGD","LU1115378108.SGD","IE00BVYPNQ40.USD","LU2424517915.HKD","BK1124","LU0762541174.USD","LU1044875133.USD","LU1008478684.HKD","LU1808992512.USD","LU0173614495.USD","LU0516423091.SGD","LU0326950275.SGD","BK1535","LU2293587155.HKD","IE00B3M56506.USD","LU0865486749.SGD","LU0096374516.USD","LU2476274308.USD","603259","BK1163","BK1583","LU0181495838.USD","LU0543330566.HKD","LU0417516902.SGD","LU1251922891.USD","600860"],"gpt_icon":1},{"id":"2614875835","title":"药明康德盘中异动 股价大涨3.04%报118.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614875835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614875835?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:36","pubTimestamp":1772156179,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘09时36分，药明康德股票出现波动，股价急速拉升3.04%。截至发稿，该股报118.800港元/股，成交量42.1703万股，换手率0.08%，振幅2.43%。资金方面，该股资金流入2603.89万港元，流出1385.17万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体涨幅为0.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709361997a73810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709361997a73810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","LU1046422090.SGD","02359","BK1141","LU0320764599.SGD","LU2045819591.USD","BK1576","BK1583"],"gpt_icon":0},{"id":"2614835360","title":"头部CRO剥离CDMO业务，药明康德、康龙化成是劲敌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614835360","media":"盖德视界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614835360?lang=zh_cn&edition=full","pubTime":"2026-02-27 08:04","pubTimestamp":1772150646,"startTime":"0","endTime":"0","summary":"CRL完成全部CDMO业务和部分欧洲发现服务资产的剥离，表明公司正在优化业务结构，聚焦于临床前阶段的核心竞争力。第三方分析报道显示，这家临床前CRO，在全球市场，尤其是欧美市场很可能正面临来自中国CRO药明康德和康龙化成的强力挑战。该分析文章指出，CRL的核心业务是DSA，与中国的CRO巨头有直接的竞争关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227081639a7242bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227081639a7242bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0320764599.SGD","BK1576","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","LU0052750758.USD","02359","BK1141","03759","LU2045819591.USD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2614806610","title":"每日卖空追踪 | 药明康德 02月25日卖空量成交29.56万股，卖空比例为10.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614806610","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614806610?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008233,"startTime":"0","endTime":"0","summary":"药明康德北京时间02月25日，跌0.66%，卖空量成交29.56万股，较上一交易日减少60.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163416a4c6752f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163416a4c6752f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0708995583.HKD","LU2242644610.SGD","LU2125910500.SGD","LU1046422090.SGD","LU2045819591.USD","LU0320764599.SGD","02359","LU0052750758.USD","BK1576","BK1583"],"gpt_icon":0},{"id":"2614747108","title":"节后A股首个交易日 年轻人的“药理财”表现如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747108","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747108?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:38","pubTimestamp":1771936713,"startTime":"0","endTime":"0","summary":"2月24日，A股节后首个交易日，医药商业板块和医疗器械板块领涨，分别上涨1.28%和0.66%，化学制药上涨0.50%，拉长时间线看，创新药、CXO、高端医疗器械等板块正加速复苏。这一表现，也将创下公司上市以来归母净利润的历史新高。昔日“疫苗之王”智飞生物，自上市以来首次年报亏损。目前，智飞生物的代理产品收入占比高达90%，其代理的默沙东HPV疫苗业务缩水，是其业绩下滑的关键因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1574","BK1576","BK1161","BK1141","06127","LU2125910500.SGD","BK1583","LU0052750758.USD","09995","09969","06978","02315","LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","LU0320764599.SGD","03347","LU2045819591.USD","02359"],"gpt_icon":0},{"id":"2614747106","title":"药明康德盘中异动 急速下挫3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747106?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:46","pubTimestamp":1771897565,"startTime":"0","endTime":"0","summary":"2026年02月24日早盘09时46分，药明康德股票出现波动，股价快速下跌3.06%。截至发稿，该股报123.400港元/股，成交量38.9825万股，换手率0.08%，振幅2.51%。资金方面，该股资金流入2541.33万港元，流出1566.68万港元。机构评级方面，在所有19家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。药明康德股票所在的生物技术行业中，整体跌幅为0.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602240946059541b772&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602240946059541b772&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","LU2125910500.SGD","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","BK1576","02359","LU0708995583.HKD","BK1583","LU2242644610.SGD","BK1141"],"gpt_icon":0},{"id":"2613755774","title":"【读财报】医药生物行业2025年业绩预告透视：五成公司预喜 药明康德、三生国健等10家公司预盈超10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613755774","media":"新华财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613755774?lang=zh_cn&edition=full","pubTime":"2026-02-24 07:20","pubTimestamp":1771888844,"startTime":"0","endTime":"0","summary":"新华财经北京2月24日电截至2026年2月12日，根据申万行业分类，A股医药生物行业逾500家上市公司，其中约274家已披露2025年业绩预告。整体来看，已披露2025年业绩预告的274家医药生物上市公司中，业绩偏正面（包括预增、略增、扭亏及续盈）的企业合计90家。137家医药生物上市公司2025年实现盈利，占比50%，其中10家归母净利润超10亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602243652109539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","163118","000808.SH","603259","688336"],"gpt_icon":0},{"id":"2613878448","title":"中信建投：节后A股有望开启新一轮上行 坚持“科技+资源品”双主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2613878448","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613878448?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:41","pubTimestamp":1771850460,"startTime":"0","endTime":"0","summary":"人民财讯2月23日电，中信建投证券研报认为，春节期间全球股市整体强势，无重大风险事件，当前市场情绪仍然高涨，节后A股有望开启新一轮上行。行业配置上继续坚持“科技+资源品”双主线。其中科技主线以AI、人形机器人、新能源和创新药为核心，资源品主线以贵金属、石油石化、基础化工为核心。重点关注板块包括：半导体、AI（光通信、液冷、电子布、高端铜箔等）、机械、有色、石油石化、基础化工、电力设备（储能、特高压、光伏、固态电池等）、创新药等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223204221a4bf0b73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223204221a4bf0b73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1807302812.USD","LU1152091168.USD","03750","02899","BK1116","LU0880133367.SGD","LU1960683339.HKD","02359","06066","LU1008478684.HKD","LU1993786604.SGD","LU1152091754.HKD","601066","LU0067412154.USD","BK1610"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.059},{"period":"1month","weight":-0.0172},{"period":"3month","weight":0.0534},{"period":"6month","weight":-0.0416},{"period":"1year","weight":0.8479},{"period":"ytd","weight":0.0993}],"compareEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":-0.0564},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.0038},{"period":"1year","weight":0.0732},{"period":"ytd","weight":-0.0121}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026724},{"month":2,"riseRate":0.5,"avgChangeRate":0.002978},{"month":3,"riseRate":0.375,"avgChangeRate":-0.020192},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038238}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}